220 related articles for article (PubMed ID: 27237378)
1. Loss of Asxl1 Alters Self-Renewal and Cell Fate of Bone Marrow Stromal Cell, Leading to Bohring-Opitz-like Syndrome in Mice.
Zhang P; Xing C; Rhodes SD; He Y; Deng K; Li Z; He F; Zhu C; Nguyen L; Zhou Y; Chen S; Mohammad KS; Guise TA; Abdel-Wahab O; Xu M; Wang QF; Yang FC
Stem Cell Reports; 2016 Jun; 6(6):914-925. PubMed ID: 27237378
[TBL] [Abstract][Full Text] [Related]
2. Screening of CD96 and ASXL1 in 11 patients with Opitz C or Bohring-Opitz syndromes.
Urreizti R; Roca-Ayats N; Trepat J; Garcia-Garcia F; Aleman A; Orteschi D; Marangi G; Neri G; Opitz JM; Dopazo J; Cormand B; Vilageliu L; Balcells S; Grinberg D
Am J Med Genet A; 2016 Jan; 170A(1):24-31. PubMed ID: 26768331
[TBL] [Abstract][Full Text] [Related]
3. Pathological ASXL1 Mutations and Protein Variants Impair Neural Crest Development.
Matheus F; Rusha E; Rehimi R; Molitor L; Pertek A; Modic M; Feederle R; Flatley A; Kremmer E; Geerlof A; Rishko V; Rada-Iglesias A; Drukker M
Stem Cell Reports; 2019 May; 12(5):861-868. PubMed ID: 31006630
[TBL] [Abstract][Full Text] [Related]
4. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome.
Hoischen A; van Bon BW; Rodríguez-Santiago B; Gilissen C; Vissers LE; de Vries P; Janssen I; van Lier B; Hastings R; Smithson SF; Newbury-Ecob R; Kjaergaard S; Goodship J; McGowan R; Bartholdi D; Rauch A; Peippo M; Cobben JM; Wieczorek D; Gillessen-Kaesbach G; Veltman JA; Brunner HG; de Vries BB
Nat Genet; 2011 Jun; 43(8):729-31. PubMed ID: 21706002
[TBL] [Abstract][Full Text] [Related]
5. Clinical management of patients with ASXL1 mutations and Bohring-Opitz syndrome, emphasizing the need for Wilms tumor surveillance.
Russell B; Johnston JJ; Biesecker LG; Kramer N; Pickart A; Rhead W; Tan WH; Brownstein CA; Kate Clarkson L; Dobson A; Rosenberg AZ; Vergano SA; Helm BM; Harrison RE; Graham JM
Am J Med Genet A; 2015 Sep; 167A(9):2122-31. PubMed ID: 25921057
[TBL] [Abstract][Full Text] [Related]
6. Bohring-Opitz syndrome (BOS) with a new ASXL1 pathogenic variant: Review of the most prevalent molecular and phenotypic features of the syndrome.
Dangiolo SB; Wilson A; Jobanputra V; Anyane-Yeboa K
Am J Med Genet A; 2015 Dec; 167A(12):3161-6. PubMed ID: 26364555
[TBL] [Abstract][Full Text] [Related]
7. Matrix remodeling associated 7 promotes differentiation of bone marrow mesenchymal stem cells toward osteoblasts.
Zhou Z; Shen Y; Yin J; Xi F; Xu R; Lin D; Saijilafu ; Chen J; Wang Y
J Cell Physiol; 2019 Aug; 234(10):18053-18064. PubMed ID: 30843215
[TBL] [Abstract][Full Text] [Related]
8. Novel truncating mutations in ASXL1 identified in two boys with Bohring-Opitz syndrome.
Zhao J; Hou Y; Fang F; Ding C; Yang X; Li J; Cui D; Cao Z; Zhang H
Eur J Med Genet; 2021 Mar; 64(3):104155. PubMed ID: 33529703
[TBL] [Abstract][Full Text] [Related]
9. Loss of Asxl1 leads to myelodysplastic syndrome-like disease in mice.
Wang J; Li Z; He Y; Pan F; Chen S; Rhodes S; Nguyen L; Yuan J; Jiang L; Yang X; Weeks O; Liu Z; Zhou J; Ni H; Cai CL; Xu M; Yang FC
Blood; 2014 Jan; 123(4):541-53. PubMed ID: 24255920
[TBL] [Abstract][Full Text] [Related]
10. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.
Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A
Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772
[TBL] [Abstract][Full Text] [Related]
11. Astragalus Polysaccharide Attenuated Iron Overload-Induced Dysfunction of Mesenchymal Stem Cells via Suppressing Mitochondrial ROS.
Yang F; Yan G; Li Y; Han Z; Zhang L; Chen S; Feng C; Huang Q; Ding F; Yu Y; Bi C; Cai B; Yang L
Cell Physiol Biochem; 2016; 39(4):1369-79. PubMed ID: 27607448
[TBL] [Abstract][Full Text] [Related]
12. Two novel patients with Bohring-Opitz syndrome caused by de novo ASXL1 mutations.
Magini P; Della Monica M; Uzielli ML; Mongelli P; Scarselli G; Gambineri E; Scarano G; Seri M
Am J Med Genet A; 2012 Apr; 158A(4):917-21. PubMed ID: 22419483
[TBL] [Abstract][Full Text] [Related]
13. Bohring-Opitz syndrome caused by an ASXL1 mutation inherited from a germline mosaic mother.
Bedoukian E; Copenheaver D; Bale S; Deardorff M
Am J Med Genet A; 2018 May; 176(5):1249-1252. PubMed ID: 29681100
[TBL] [Abstract][Full Text] [Related]
14. Extending the phenotypic spectrum of Bohring-Opitz syndrome: Mild case confirmed by functional studies.
Leon E; Diaz J; Castilla-Vallmanya L; Grinberg D; Balcells S; Urreizti R
Am J Med Genet A; 2020 Jan; 182(1):201-204. PubMed ID: 31692235
[TBL] [Abstract][Full Text] [Related]
15. A novel de-novo frameshift mutation of the ASXL1 gene in a classic case of Bohring-Opitz syndrome.
Arunachal G; Danda S; Omprakash S; Kumar S
Clin Dysmorphol; 2016 Jul; 25(3):101-5. PubMed ID: 27043953
[No Abstract] [Full Text] [Related]
16. Regulation of human skeletal stem cells differentiation by Dlk1/Pref-1.
Abdallah BM; Jensen CH; Gutierrez G; Leslie RG; Jensen TG; Kassem M
J Bone Miner Res; 2004 May; 19(5):841-52. PubMed ID: 15068508
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic ASXL1 somatic variants in reference databases complicate germline variant interpretation for Bohring-Opitz Syndrome.
Carlston CM; O'Donnell-Luria AH; Underhill HR; Cummings BB; Weisburd B; Minikel EV; Birnbaum DP; ; Tvrdik T; MacArthur DG; Mao R
Hum Mutat; 2017 May; 38(5):517-523. PubMed ID: 28229513
[TBL] [Abstract][Full Text] [Related]
18. In-vitro characterization of canine multipotent stromal cells isolated from synovium, bone marrow, and adipose tissue: a donor-matched comparative study.
Bearden RN; Huggins SS; Cummings KJ; Smith R; Gregory CA; Saunders WB
Stem Cell Res Ther; 2017 Oct; 8(1):218. PubMed ID: 28974260
[TBL] [Abstract][Full Text] [Related]
19. Loss of ASXL1 in the bone marrow niche dysregulates hematopoietic stem and progenitor cell fates.
Zhang P; Chen Z; Li R; Guo Y; Shi H; Bai J; Yang H; Sheng M; Li Z; Li Z; Li J; Chen S; Yuan W; Cheng T; Xu M; Zhou Y; Yang FC
Cell Discov; 2018; 4():4. PubMed ID: 29423272
[TBL] [Abstract][Full Text] [Related]
20. Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo.
Abdel-Wahab O; Gao J; Adli M; Dey A; Trimarchi T; Chung YR; Kuscu C; Hricik T; Ndiaye-Lobry D; Lafave LM; Koche R; Shih AH; Guryanova OA; Kim E; Li S; Pandey S; Shin JY; Telis L; Liu J; Bhatt PK; Monette S; Zhao X; Mason CE; Park CY; Bernstein BE; Aifantis I; Levine RL
J Exp Med; 2013 Nov; 210(12):2641-59. PubMed ID: 24218140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
